Key result
Compared to men, women hospitalized with chronic atrial fibrillation were significantly more likely to present with symptoms (OR 1.93) and had higher thrombo-embolic risk profiles despite receiving similar treatment regimens.
Why the study?
Do gender-based differences exist in the clinical presentation, thrombo-embolic risk and therapeutic management of high risk patients hospitalised with chronic AF?
Cross-Sectional (n=335)
Yes
Do gender-based differences exist in the clinical presentation, thrombo-embolic risk and therapeutic management of high risk patients hospitalised with chronic AF?
Odds Ratio: 1.93 (95% CI 1.06–3.52)
Women hospitalized with chronic AF present with a higher thrombo-embolic risk, different comorbidity profiles, and greater psychosocial vulnerabilities compared to men, highlighting the need for individualized management.
No takes yet. Share an insight, caveat, or question.
May warrant closer symptom evaluation in women with chronic AF; leaves open whether sex-specific strategies improve outcomes.
Ball et al. (2013) conducted a cross-sectional in Chronic Atrial Fibrillation (n=335). Female sex vs. Male sex was evaluated on Symptomatic presentation (age-adjusted) (OR 1.93, 95% CI 1.06-3.52). Compared to men, women hospitalized with chronic atrial fibrillation were significantly more likely to present with symptoms (OR 1.93) and had higher thrombo-embolic risk profiles despite receiving similar treatment regimens.